Contact Us   |   Print Page   |   Sign In   |   Join
BioArbor: Intellectual Property Value and Product Novelty as Drivers of Success
Tell a Friend About This EventTell a Friend

One hour of food and networking followed by a panel discussion on the value of intellectual property and product novelty.

When: Wednesday, October 9, 2019
5:30 - 7:30 pm
Where: Ann Arbor SPARK Central Innovation Center
330 E. Liberty Street
Ann Arbor 48104
United States
Contact: Alisha Brown

Online registration is closed.
« Go to Upcoming Event List  



Intellectual Property Value and Product Novelty as Drivers of Success


Acquirers, strategic partners and investors sometimes depict a business as a horse race where corporate leadership is the jockey, the company or the technology is the horse, and the business trajectory withing the competitive environment as the race itself. Using that visualization many people assume that the jockey, or leadership, is the most important factor in a company's ultimate success - after all, they are driving the horse. However, that is an incomplete picture, and what our community of business leaders see time and again is that it's never just about the jockey.  The horse, or the novelty of the technology and value of the intellectual property, are also critical factors contributing to business success and ignoring the partnership between the company and the leadership is a recipe for disaster.


Join us for a lively discussion on strategies for bolstering company success focused around IP strategy and effective product/market development.  





 Ashley Sloat, PhD, President, Aurora Consulting

Ashley  is a USPTO-registered patent practitioner who specializes in the development and management of patent portfolios for startup ventures and emerging growth companies. She takes a hands-on approach with each client, partnering with Engineering and Management teams to intimately understand each client’s business, competition, and product vision. Armed with this knowledge, Ashley is able to increase the value of her clients’ patent portfolios while reducing overall legal costs.

Ashley has significant experience building patent portfolios directed to a diverse array of technologies. Previously, with Silicon Valley’s Hudak Consulting Group LLC, a Schox Patent Group spin off, Ashley drafted and prosecuted patent applications for robotic systems, intracardiac devices, wireless healthcare technologies, physical activity equipment, biotechnologies, surgical training systems, topical drug formulations, drug repurposing, and other medical and consumer product devices. In this role, she also performed patent landscape analyses and patentability searches for healthcare technology companies.

Ashley’s company, Aurora Consulting LLC, purchased Hudak Consulting Group LLC at the end of 2016 and has maintained a similar subject matter focus. Since then, Ashley has rapidly grown the company and maintained focus on startup ventures. Aurora Consulting currently serves clients, ranging in size and technological field, throughout the U.S. and internationally. 


 Joshua Ney, Shareholder, Brinks, Gilson, and Lione

Joshua Ney is a shareholder in Brinks Gilson & Lione’s Ann Arbor office.  Dr. Ney represents pharmaceutical clients in patent litigation and prosecution matters, which includes counseling clients on the interplay between regulatory and patent strategy.  His experience spans a range of pharmaceutical modalities and therapeutic applications.



 Matthew Alves, Former VP of Strategic Development, Stryker




 Robert Shereda, PhD, Patent Agent, Brinks, Gilson and Lione

A former researcher in both academia and biotech, Rob Shereda has a knack for asking the right questions to gain a deeper understanding of complex scientific problems and their solutions. Rob brings similar tenacity and focus to Brinks, where his practice centers on patent prosecution, particularly in the chemical and biological sciences.


A biochemist by training and prolific published academic writer, Rob works with inventors to provide high-quality patent applications related to small molecule pharmaceuticals, biological therapeutics, medical devices, materials, nanotechnology, and energy - including solar and biofuels –and clients appreciate the unique insights he brings to their applications. As post-grant procedures have become common, Rob has taken the lead in compiling data about the fate of patents pertaining to the chemical sciences subjected to these procedures.


Drawing on his nearly ten years of lab-based research and keeping current in a dynamic scientific field, Rob’s curious nature and focus on experimentation enable him to think forward in serving Brinks’ clients. 





BioArbor, an entirely volunteer run organization, hosts educational networking events for the life sciences industry in the greater Ann Arbor area. BioArbor events explore technology commercialization (product, device, and service), financing strategies, business development, regulatory affairs, marketing, and other topics useful to life science entrepreneurs.


Each event, held six times per year, features a networking session, invited speaker(s), and a post-presentation Q&A period. Invited speakers from both the national and local ecosystem share experience on topics such as drug discovery and development, medical devices, diagnostics, and tools.


BioArbor events are open to the public and are especially suited for those interested in starting or growing life science businesses.


BioArbor is generously sponsored by:



Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal